Aarti Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 521.35 | 624.67 | 525.91 |
| Operating Expense | 457.01 | 534.31 | 454.29 |
| Net Profit | 48.64 | 61.48 | 38.53 |
| Net Profit Margin | 9.33 | 9.84 | 7.33 |
| Earning Per Share | 5.33 | 6.74 | 4.22 |
| EBIDTA | 62.34 | 90.86 | 70.12 |
| Effective Tax Rate | -8.38 | 10.72 | 16.76 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 521.35 |
| Operating Expense | 457.01 |
| Net Profit | 48.64 |
| Net Profit Margin | 9.33 |
| Earning Per Share | 5.33 |
| EBIDTA | 62.34 |
| Effective Tax Rate | -8.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2,173.65 | 2,266.91 | 2,497.97 |
| Operating Expenses Annual | 1,911.00 | 2,000.78 | 2,215.57 |
| Operating Profit Annual | 276.22 | 270.31 | 284.64 |
| Interest Annual | 29.68 | 30.16 | 32.53 |
| Depreciation | 46.54 | 45.50 | 44.64 |
| Net Profit Annual | 157.31 | 141.88 | 152.81 |
| Tax Annual | 41.44 | 50.60 | 52 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2,173.65 |
| Operating Expenses Annual | 1,911.00 |
| Operating Profit Annual | 276.22 |
| Interest Annual | 29.68 |
| Depreciation | 46.54 |
| Net Profit Annual | 157.31 |
| Tax Annual | 41.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.72 | 1.52 | 1.49 |
| Cash Flow from Operations | 220.08 | 337.10 | 161.70 |
| Cash Flow from Investing | -134.92 | -187.09 | -131.14 |
| Cash Flow from Financing | -84.60 | -148.81 | -30.54 |
| Cash Flow at the End | 3.28 | 2.72 | 1.52 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 2.72 |
| Cash Flow from Operations | 220.08 |
| Cash Flow from Investing | -134.92 |
| Cash Flow from Financing | -84.60 |
| Cash Flow at the End | 3.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 12.82 | 12.06 | 11.54 |
| PBIT Margin (%) | 10.62 | 9.96 | 9.65 |
| PBT Margin (%) | 10.29 | 9.66 | 9.38 |
| Net PROFIT Margin (%) | 7.24 | 6.26 | 6.12 |
| Return On Networth / Equity (%) | 12.97 | 12.39 | 14.65 |
| Return On Networth /Employed (%) | 13.49 | 13.65 | 15.24 |
| Return On Assets (%) | 9.19 | 8.57 | 9.67 |
| Total Debt / Equity (X) | 0.41 | 0.44 | 0.51 |
| Asset Turnover Ratio (%) | 1.27 | 1.37 | 1.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 12.82 |
| PBIT Margin (%) | 10.62 |
| PBT Margin (%) | 10.29 |
| Net PROFIT Margin (%) | 7.24 |
| Return On Networth / Equity (%) | 12.97 |
| Return On Networth /Employed (%) | 13.49 |
| Return On Assets (%) | 9.19 |
| Total Debt / Equity (X) | 0.41 |
| Asset Turnover Ratio (%) | 1.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 761.23 | 722.29 | 634.48 |
| Total Current Assets Annual | 1,180.56 | 1,181.02 | 1,349.53 |
| Non Current Assets Annual | 1,092.23 | 990.60 | 845.96 |
| Total Shareholders Funds Annual | 1,251.35 | 1,175.21 | 1,114.30 |
| Total Assets Annual | 2,272.79 | 2,171.62 | 2,195.50 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 761.23 |
| Total Current Assets Annual | 1,180.56 |
| Non Current Assets Annual | 1,092.23 |
| Total Shareholders Funds Annual | 1,251.35 |
| Total Assets Annual | 2,272.79 |
EPS (INR)
Expected
5.91
Reported
5.91
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.15%
Sep 2024
EPS beaten by 0.00%
